Brief: Bioretec Gets FDA Breakthrough Device Designation Status For Remeos Spinal Interbody Cage
14/03/2024 14:19
March 14 (Reuters) - Bioretec Oy BRETEC.HE :
* BIORETEC HAS BEEN GRANTED FDA BREAKTHROUGH DEVICE
DESIGNATION
STATUS FOR ITS REMEOS™ SPINAL INTERBODY CAGE
Source text for Eikon: ID:nWkr78ShM3
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million